Steve Chan
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Journal: Nature
Published: February 06, 2024
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 23, 2023
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.
Journal: Histopathology
Published: April 07, 2022
Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 02, 2019
Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: January 23, 2018
SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 21, 2014
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer.
Journal: Breast cancer research and treatment
Published: March 17, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026